What is the equity of Biosenic this year?
Biosenic has equity of 3.53 M EUR this year.
Biosenic Equity 2025
Biosenic Equity
3.53 M EUR
Ticker
BIOS.BR
ISIN
BE0974280126
WKN
A14NHV
In 2025, Biosenic's equity was 3.53 M EUR, a 0% increase from the 0 EUR equity in the previous year.
Biosenic Aktienanalyse
What does Biosenic do?
Bone Therapeutics SA is a Belgian company specializing in the development of innovative therapies for bone and joint diseases. Its goal is to treat patients with severe orthopedic conditions and help improve their quality of life. The company's business model is based on extensive research and development strategies aimed at developing groundbreaking therapies for diseases such as fractures, osteoporosis, osteoarthritis, and other bone and joint-related conditions. It focuses on the development of innovative stem cell-based therapies that help repair damaged tissues and promote self-regeneration. Additionally, Bone Therapeutics has developed a special cell therapy called Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells, targeting cartilage growth as an alternative, cell-based therapy for knee and hip osteoarthritis. It has also developed a platform called Allogeneic Osteoblastic Cells, aiming to treat ligament and tendon injuries. The company conducts research and clinical studies in collaboration with academic partners to improve its therapies and develop new products and solutions. It operates in three business areas: Orthobiology, Cardiology, and Immunology, focusing on the development and marketing of therapies for bone and joint arthritis, cardiovascular diseases, and autoimmune diseases, respectively. Its current product offerings include Allob, AlgoScaff, and JTA-004 for the treatment of orthopedic conditions such as fractured vertebrae, severe bone injuries, bone regeneration, osteoporosis, and osteoarthritis. Bone Therapeutics is headquartered in Gosselies, Belgium, with offices in the US, France, Germany, and Italy. Its mission is to advance the development of therapies for bone and joint diseases and assist patients with severe orthopedic conditions. Through its research and development strategies, collaboration with academic partners, and strong market position, Bone Therapeutics aims to make a difference in the field. Biosenic ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Biosenic's Equity
Biosenic's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Biosenic's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Biosenic's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Biosenic's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Biosenic’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Biosenic stock
What was the equity of Biosenic compared to the previous year?
The equity of Biosenic has increased/decreased by 0% decreased compared to the previous year.
What impact does a high equity have on investors of Biosenic?
A high equity is advantageous for investors of Biosenic as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Biosenic?
A low equity can be a risk for investors of Biosenic, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Biosenic affect the company?
An increase in equity of Biosenic can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Biosenic affect the company?
A reduction in equity of Biosenic can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Biosenic?
Some factors that can affect the equity of Biosenic include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Biosenic so important for investors?
The equity of Biosenic is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Biosenic take to change the equity?
To change equity, Biosenic can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Biosenic pay?
Over the past 12 months, Biosenic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biosenic is expected to pay a dividend of 0 EUR.
What is the dividend yield of Biosenic?
The current dividend yield of Biosenic is .
When does Biosenic pay dividends?
Biosenic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Biosenic?
Biosenic paid dividends every year for the past 0 years.
What is the dividend of Biosenic?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Biosenic located?
Biosenic is assigned to the 'Health' sector.
Wann musste ich die Aktien von Biosenic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Biosenic from 2/21/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 2/21/2025.
When did Biosenic pay the last dividend?
The last dividend was paid out on 2/21/2025.
What was the dividend of Biosenic in the year 2024?
In the year 2024, Biosenic distributed 0 EUR as dividends.
In which currency does Biosenic pay out the dividend?
The dividends of Biosenic are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Biosenic
Our stock analysis for Biosenic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosenic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.